FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2756839833> ?p ?o ?g. }

• W2756839833 endingPage "7590" @default.
• W2756839833 startingPage "7585" @default.
• W2756839833 abstract "Kisspeptin is a protein encoded by the KISS1 gene, which has been reported to suppress the metastatic capabilities of various types of cancer cells, through the activation of its G‑protein coupled receptor GPR54. However, the molecular mechanisms underlying the involvement of kisspeptin‑mediated signaling in the inhibition of cancer cell migration and invasion have yet to be elucidated. The present in vitro cell proliferation, migration and invasion assays and in vivo experimental metastasis studies demonstrated that kisspeptin‑induced eukaryotic translation initiation factor 2α kinase 2 (EIF2AK2) activation suppressed the metastatic capabilities of several types of cancer cells. Kisspeptin was revealed to inhibit the migratory and invasive abilities of highly metastatic breast SK‑BR‑3, prostatic PC‑3 and colorectal adenocarcinoma LoVo human cancer cell lines, whereas its inhibitory effects were abolished following the silencing of EIF2AK2 expression using RNA interference. Similarly, kisspeptin failed to inhibit the migration and invasion of mouse embryonic fibroblasts following the deletion of the EIF2AK2 gene. Furthermore, kisspeptin was demonstrated to activate Ras homolog gene family member A (RhoA)‑dependent signaling, and to phosphorylate EIF2AK2 via RhoA‑mediated pathways in various cancer cells. In addition, results obtained from nude mice bearing LoVo‑derived xenograft tumors revealed that kisspeptin inhibited tumor growth through an EIF2AK2‑dependent mechanism, and an in vivo metastasis assay identified kisspeptin‑activated EIF2AK2 signaling as critical for the suppression of distant metastasis. The present study concluded that kisspeptin represses cancer metastasis via EIF2AK2 signaling, thus clarifying the role of kisspeptin signaling in complicated cancer metastasis signaling network. Therefore, kisspeptin treatment may be a choice for blocking metastases." @default.
• W2756839833 created "2017-10-06" @default.
• W2756839833 creator A5038847231 @default.
• W2756839833 creator A5057664407 @default.
• W2756839833 date "2017-05-01" @default.
• W2756839833 modified "2023-09-30" @default.
• W2756839833 title "Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2" @default.
• W2756839833 cites W13300045 @default.
• W2756839833 cites W1872553424 @default.
• W2756839833 cites W1880891411 @default.
• W2756839833 cites W1964267861 @default.
• W2756839833 cites W1965069248 @default.
• W2756839833 cites W1969827037 @default.
• W2756839833 cites W1970577562 @default.
• W2756839833 cites W1970812281 @default.
• W2756839833 cites W1975634792 @default.
• W2756839833 cites W1981945864 @default.
• W2756839833 cites W1994150008 @default.
• W2756839833 cites W1999592964 @default.
• W2756839833 cites W2047391267 @default.
• W2756839833 cites W2054033311 @default.
• W2756839833 cites W2056258340 @default.
• W2756839833 cites W2069499122 @default.
• W2756839833 cites W2098921256 @default.
• W2756839833 cites W2108635648 @default.
• W2756839833 cites W2109320923 @default.
• W2756839833 cites W2111824942 @default.
• W2756839833 cites W2116458487 @default.
• W2756839833 cites W2131759869 @default.
• W2756839833 cites W2138657304 @default.
• W2756839833 cites W2154492869 @default.
• W2756839833 cites W2161414290 @default.
• W2756839833 cites W2163040119 @default.
• W2756839833 cites W2321568747 @default.
• W2756839833 cites W2470325373 @default.
• W2756839833 cites W45641751 @default.
• W2756839833 doi "https://doi.org/10.3892/mmr.2017.7578" @default.
• W2756839833 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28944853" @default.
• W2756839833 hasPublicationYear "2017" @default.
• W2756839833 type Work @default.
• W2756839833 sameAs 2756839833 @default.
• W2756839833 citedByCount "14" @default.
• W2756839833 countsByYear W27568398332018 @default.
• W2756839833 countsByYear W27568398332019 @default.
• W2756839833 countsByYear W27568398332020 @default.
• W2756839833 countsByYear W27568398332022 @default.
• W2756839833 countsByYear W27568398332023 @default.
• W2756839833 crossrefType "journal-article" @default.
• W2756839833 hasAuthorship W2756839833A5038847231 @default.
• W2756839833 hasAuthorship W2756839833A5057664407 @default.
• W2756839833 hasBestOaLocation W27568398331 @default.
• W2756839833 hasConcept C104317684 @default.
• W2756839833 hasConcept C119056186 @default.
• W2756839833 hasConcept C121608353 @default.
• W2756839833 hasConcept C137738243 @default.
• W2756839833 hasConcept C1491633281 @default.
• W2756839833 hasConcept C170493617 @default.
• W2756839833 hasConcept C2776808119 @default.
• W2756839833 hasConcept C2777093181 @default.
• W2756839833 hasConcept C2779013556 @default.
• W2756839833 hasConcept C2781018059 @default.
• W2756839833 hasConcept C29537977 @default.
• W2756839833 hasConcept C502942594 @default.
• W2756839833 hasConcept C54355233 @default.
• W2756839833 hasConcept C62478195 @default.
• W2756839833 hasConcept C86803240 @default.
• W2756839833 hasConcept C95444343 @default.
• W2756839833 hasConcept C96232424 @default.
• W2756839833 hasConceptScore W2756839833C104317684 @default.
• W2756839833 hasConceptScore W2756839833C119056186 @default.
• W2756839833 hasConceptScore W2756839833C121608353 @default.
• W2756839833 hasConceptScore W2756839833C137738243 @default.
• W2756839833 hasConceptScore W2756839833C1491633281 @default.
• W2756839833 hasConceptScore W2756839833C170493617 @default.
• W2756839833 hasConceptScore W2756839833C2776808119 @default.
• W2756839833 hasConceptScore W2756839833C2777093181 @default.
• W2756839833 hasConceptScore W2756839833C2779013556 @default.
• W2756839833 hasConceptScore W2756839833C2781018059 @default.
• W2756839833 hasConceptScore W2756839833C29537977 @default.
• W2756839833 hasConceptScore W2756839833C502942594 @default.
• W2756839833 hasConceptScore W2756839833C54355233 @default.
• W2756839833 hasConceptScore W2756839833C62478195 @default.
• W2756839833 hasConceptScore W2756839833C86803240 @default.
• W2756839833 hasConceptScore W2756839833C95444343 @default.
• W2756839833 hasConceptScore W2756839833C96232424 @default.
• W2756839833 hasIssue "5" @default.
• W2756839833 hasLocation W27568398331 @default.
• W2756839833 hasLocation W27568398332 @default.
• W2756839833 hasOpenAccess W2756839833 @default.
• W2756839833 hasPrimaryLocation W27568398331 @default.
• W2756839833 hasRelatedWork W1975859778 @default.
• W2756839833 hasRelatedWork W2022322735 @default.
• W2756839833 hasRelatedWork W2042520059 @default.
• W2756839833 hasRelatedWork W2050525013 @default.
• W2756839833 hasRelatedWork W2514025656 @default.
• W2756839833 hasRelatedWork W2772993264 @default.
• W2756839833 hasRelatedWork W2942001228 @default.
• W2756839833 hasRelatedWork W3119915123 @default.

• next